TRPC5 Channel Inhibition Protects Podocytes in Puromycin-Aminonucleoside Induced Nephrosis Models.

Zhou, Yiming; Kim, Choah; Pablo, Juan Lorenzo B; Zhang, Fan; Jung, Ji Yong; Xiao, Li; Bazua-Valenti, Silvana; Emani, Maheswarareddy; Hopkins, Corey R; Weins, Astrid; Greka, Anna

Zhou, Yiming; Kim, Choah; Pablo, Juan Lorenzo B; Zhang, Fan; Jung, Ji Yong; Xiao, Li; Bazua-Valenti, Silvana; Emani, Maheswarareddy; Hopkins, Corey R; Weins, Astrid; Greka, Anna.

Afiliação

Zhou Y; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Kim C; Center for the Development of Therapeutics (CDoT), Broad Institute of MIT and Harvard, Cambridge, MA, United States.
Pablo JLB; Center for the Development of Therapeutics (CDoT), Broad Institute of MIT and Harvard, Cambridge, MA, United States.
Zhang F; Center for the Development of Therapeutics (CDoT), Broad Institute of MIT and Harvard, Cambridge, MA, United States.
Jung JY; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Xiao L; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Bazua-Valenti S; Department of Internal Medicine, Gachon University Gil Medical Center, College of Medicine, Incheon, South Korea.
Emani M; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Hopkins CR; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Weins A; Center for the Development of Therapeutics (CDoT), Broad Institute of MIT and Harvard, Cambridge, MA, United States.
Greka A; Center for the Development of Therapeutics (CDoT), Broad Institute of MIT and Harvard, Cambridge, MA, United States.